The role of H3K4me3 in transcriptional regulation is altered in Huntington's disease

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Dong, Xianjun ^a,e   Tsuji, Junko ^a   Labadorf, Adam ^b,c   Roussos, Panos ^d   Chen, Jiang Fan ^b   Myers, Richard H ^b,c   Akbarian, Schahram ^d   Weng, Zhiping ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; MESSENGER RNA; POLYCOMB REPRESSIVE COMPLEX 2; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CCNT2; TRANSCRIPTION FACTOR E2F6; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR HMGN3; TRANSCRIPTION FACTOR SUZ12; TRANSCRIPTION FACTOR ZBTB7A; UNCLASSIFIED DRUG; EZH2 PROTEIN, HUMAN; HISTONE; HTT PROTEIN, HUMAN; HUNTINGTIN; NERVE PROTEIN; SUZ12 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; MIDDLE AGED; MORPHOGENESIS; PREFRONTAL CORTEX; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VERY ELDERLY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY;

ADULT; AGED; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; FEMALE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HISTONES; HUMANS; HUNTINGTIN PROTEIN; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYCOMB REPRESSIVE COMPLEX 2; PREFRONTAL CORTEX; TRANSCRIPTION, GENETIC;

EID: 84955598221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144398     Document Type: Article

References (88)

1. Huntington G. On Chorea. Med Surg Report. 1872; 26: 317-321.
2. Myers RH. Huntington's disease genetics. NeuroRx. 2004; 1: 255-62. doi: 10.1602/neurorx.1.2.255 PMID: 15717026
3. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985; 44: 559-577. doi: 10.1097/00005072- 198511000-00003 PMID: 2932539
4. Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology. 1991; 41: 1117-1123. doi: 10.1212/WNL.41.7.1117 PMID: 1829794
5. Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, et al. PRECREST: A phase II prevention and biomarker trial of creatine in at-risk huntington disease. Neurology. 2014; 82: 850-857. doi: 10.1212/WNL0000000000000187 PMID: 24510496
6. Macdonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A Novel Gene Containing A Trinucleotide Repeat That Is Expanded and Unstable on Huntingtons-Disease Chromosomes. Cell. 1993; 72: 971-983. PMID: 8458085
7. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet. 1993; 4: 387-392. doi: 10.1038/ng0893-387 PMID: 8401587
8. Myers RH, MacDonald ME, Koroshetz WJ, Duyao MP, Ambrose CM, Taylor SA, et al. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nat Genet. 1993; 5: 168-173. doi: 10.1038/ng1093-168 PMID: 8252042
9. Cha JH. Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 2000; 23: 387-392. S0166-2236(00)01609-X [pii] PMID: 10941183
10. Cha JHJ. Transcriptional signatures in Huntington's disease. Progress in Neurobiology. 2007. pp. 228- 248. doi: 10.1016/j.pneurobio.2007.03.004 PMID: 17467140
11. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet. 2006; 15: 965-977. doi: 10. 1093/hmg/ddl013 PMID: 16467349
12. Hoss AG, Kartha VK, Dong X, Latourelle JC, Dumitriu A, Hadzi TC, et al. MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis. PLoS Genet. Public Library of Science; 2014; 10: E1004188. doi: 10.1371/journal.pgen.1004188 PMID: 24586208
13. Trushina E, Dyer RB, Badger JD, Ure D, Eide L, Tran DD, et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol. 2004; 24: 8195-8209. doi: 10.1128/MCB.24.18.8195-8209.2004 PMID: 15340079
14. Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: An alternative approach to Huntington's disease. Nat Rev Neurosci. 2005; 6: 919-930. doi: 10.1038/nrn1806 PMID: 16288298
15. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 2001; 413: 739-743. doi: 10.1038/35099568 PMID: 11607033
16. Nucifora FC, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science (80-). 2001; 291: 2423-2428. doi: 10.1126/science.1056784 PMID: 11264541
17. McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, et al. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS One. 2012; 7. doi: 10.1371/journal. pone.0041423
18. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, et al. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet. 2007; 16: 1293-1306. doi: 10.1093/hmg/ddm078 PMID: 17409194
19. Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci U S A. 2006; 103: 19176-19181. doi: 10.1073/pnas.0606373103 PMID: 17142323
20. Lee J, Hwang YJ, Shin JY, Lee WC, Wie J, Kim KY, et al. Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca2+ signaling in Huntington's disease. Acta Neuropathol. 2013; 125: 727-739. doi: 10.1007/s00401-013-1103-z PMID: 23455440
21. Ng CW, Yildirim F, Yap YS, Dalin S, Matthews BJ, Velez PJ, et al. Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci U S A. 2013; 110: 2354-2359. doi: 10.1073/pnas.1221292110 PMID: 23341638
22. Lee J, Hwang YJ, Kim KY, Kowall NW, Ryu H. Epigenetic Mechanisms of Neurodegeneration in Huntington's Disease. Neurotherapeutics. 2013. pp. 664-676. doi: 10.1007/s13311-013-0206-5 PMID: 24006238
23. Villar-Menéndez I, Blanch M, Tyebji S, Pereira-Veiga T, Albasanz JL, Martín M, et al. Increased 5- methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. NeuroMolecular Med. 2013; 15: 295-309. doi: 10.1007/s12017- 013-8219-0 PMID: 23385980
24. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of Lysine 4 on Histone H3: Intricacy of Writing and Reading a Single Epigenetic Mark. Molecular Cell. 2007. pp. 15-30. doi: 10.1016/j.molcel.2006.12.014
25. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-Resolution Profiling of Histone Methylations in the Human Genome. Cell. 2007; 129: 823-837. doi: 10.1016/j.cell.2007.05.009 PMID: 17512414
26. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007; 39: 311-318. doi: 10.1038/ng1966 PMID: 17277777
27. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 2005; 120: 169-181. doi: 10.1016/j.cell.2005.01.001 PMID: 15680324
28. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NCT, et al. Active genes are tri-methylated at K4 of histone H3. Nature. 2002; 419: 407-411. doi: 10.1038/nature01080 PMID: 12353038
29. Okitsu CY, Hsieh JCF, Hsieh C-L. Transcriptional activity affects the H3K4me3 level and distribution in the coding region. Mol Cell Biol. 2010; 30: 2933-2946. doi: 10.1128/MCB.01478-09 PMID: 20404096
30. Benayoun BA, Pollina EA, Ucar D, Mahmoudi S, Karra K, Wong ED, et al. H3K4me3 breadth is linked to cell identity and transcriptional consistency. Cell. 2014; 158: 673-688. doi: 10.1016/j.cell.2014.06. 027 PMID: 25083876
31. Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH, Bodai L, et al. Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A. 2013; 110: E3027-E3036. doi: 10.1073/pnas. 1311323110 PMID: 23872847
32. Bai G, Cheung I, Shulha HP, Coelho JE, Li P, Dong X, et al. Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains. Hum Mol Genet. 2015; 24: 1441-56. doi: 10.1093/hmg/ddu561 PMID: 25480889
33. Shulha HP, Cheung I, Guo Y, Akbarian S, Weng Z. Coordinated Cell Type-Specific Epigenetic Remodeling in Prefrontal Cortex Begins before Birth and Continues into Early Adulthood. PLoS Genet. 2013; 9. doi: 10.1371/journal.pgen.1003433
34. Shulha HP, Crisci JL, Reshetov D, Tushir JS, Cheung I, Bharadwaj R, et al. Human-Specific Histone Methylation Signatures at Transcription Start Sites in Prefrontal Neurons. PLoS Biol. 2012; 10. doi: 10. 1371/journal.pbio.1001427
35. Cheung I, Shulha HP, Jiang Y, Matevossian A, Wang J, Weng Z, et al. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc Natl Acad Sci U S A. 2010; 107: 8824-8829. doi: 10.1073/pnas.1001702107 PMID: 20421462
36. Hoss AG, Labadorf A, Latourelle JC, Kartha VK, Hadzi TC, Gusella JF, et al. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement. BMC Med Genomics. 2015; 8: 10. doi: 10.1186/s12920-015-0083-3 PMID: 25889241
37. Dong X, Greven MC, Kundaje A, Djebali S, Brown JB, Cheng C, et al. Modeling gene expression using chromatin features in various cellular contexts. Genome Biol. 2012; 13: R53. doi: 10.1186/gb-2012-13- 9-r53 PMID: 22950368
38. Sato S, Omori Y, Katoh K, Kondo M, Kanagawa M, Miyata K, et al. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci. 2008; 11: 923-931. doi: 10.1038/nn.2160 PMID: 18641643
39. Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998; 21: 309-345. doi: 10.1146/annurev.neuro.21.1.309 PMID: 9530499
40. Wilkinson DG. Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci. 2001; 2: 155-64. PMID: 11256076
41. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, Kim JS, et al. A novel signaling pathway impact analysis. Bioinformatics. 2009; 25: 75-82. doi: 10.1093/bioinformatics/btn577 PMID: 18990722
42. Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al. An atlas of active enhancers across human cell types and tissues. Nature. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2014; 507: 455-61. doi: 10.1038/nature12787 PMID: 24670763
43. Kvon EZ, Stampfel G, Omar Yáññez-Cuna J, Dickson BJ, Stark A. HOT regions function as patterned developmental enhancers and have a distinct cis-regulatory signature. Genes Dev. 2012; 26: 908-913. doi: 10.1101/gad.188052.112 PMID: 22499593
44. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, et al. The accessible chromatin landscape of the human genome. Nature. 2012. pp. 75-82. doi: 10.1038/nature11232
45. Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013; 45: 1238-1243. doi: 10.1038/ng.2756 PMID: 24013639
46. Phillips JE, Corces VG. CTCF: Master Weaver of the Genome. Cell. 2009. pp. 1194-1211. doi: 10. 1016/j.cell.2009.06.001 PMID: 19563753
47. Milavetz BI. SP1 and AP-1 elements direct chromatin remodeling in SV40 chromosomes during the first 6 hours of infection. Virology. 2002; 294: 170-179. doi: 10.1006/viro.2001.1308 PMID: 11886275
48. Tan NY, Khachigian LM. Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 2009; 29: 2483-8. doi: 10.1128/MCB.01828-08 PMID: 19273606
49. Consortium RE, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et al. Integrative analysis of 111 reference human epigenomes. Nature. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2015; 518: 317-330. doi: 10.1038/nature14248 PMID: 25693563
50. Schmitges FW, Prusty AB, Faty M, Stützer A, Lingaraju GM, Aiwazian J, et al. Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks. Mol Cell. 2011; 42: 330-341. doi: 10.1016/j.molcel.2011. 03.025 PMID: 21549310
51. Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, et al. Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology. 2012; 79: 1708-1715. doi: 10. 1212/WNL.0b013e31826e9a5d PMID: 23035064
52. Jiang Y, Matevossian A, Huang H-S, Straubhaar J, Akbarian S. Isolation of neuronal chromatin from brain tissue. BMC Neurosci. 2008; 9: 42. doi: 10.1186/1471-2202-9-42 PMID: 18442397
53. Valor LM, Guiretti D, Lopez-Atalaya JP, Barco A. Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J Neurosci. 2013; 33: 10471-82. doi: 10.1523/JNEUROSCI.0670-13.2013 PMID: 23785159
54. Ravache M, Weber C, Mérienne K, Trottier Y. Transcriptional activation of REST by Sp1 in huntington's disease models. PLoS One. 2010; 5. doi: 10.1371/journal.pone.0014311
55. Qiu Z, Norflus F, Singh B, Swindell MK, Buzescu R, Bejarano M, et al. Sp1 is up-regulated in cellular and transgenic models of huntington disease, and its reduction is neuroprotective. J Biol Chem. 2006; 281: 16672-16680. doi: 10.1074/jbc.M511648200 PMID: 16595660
56. Dunah AW, Jeong H, Griffin A, Kim Y-M, Standaert DG, Hersch SM, et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 2002; 296: 2238-2243. doi: 10.1126/science.1072613 PMID: 11988536
57. Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E, et al. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J Neurosci. 2007; 27: 6972-6983. doi: 10.1523/JNEUROSCI.4278- 06.2007 PMID: 17596446
58. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003; 35: 76-83. doi: 10.1038/ng1219 PMID: 12881722
59. Sugars KL, Rubinsztein DC. Transcriptional abnormalities in Huntington disease. Trends in Genetics. 2003. pp. 233-238. doi: 10.1016/S0168-9525(03)00074-X PMID: 12711212
60. Biagioli M, Ferrari F, Mendenhall EM, Zhang Y, Erdin S, Vijayvargia R, et al. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum Mol Genet. 2015; 24: 2442-57. doi: 10.1093/hmg/ddv006 PMID: 25574027
61. Seong IS, Woda JM, Song J-J, Lloret A, Abeyrathne PD, Woo CJ, et al. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet. 2010; 19: 573-83. doi: 10.1093/hmg/ddp524 PMID: 19933700
62. Peña P V., Hom RA, Hung T, Lin H, Kuo AJ, Wong RPC, et al. Histone H3K4me3 Binding Is Required for the DNA Repair and Apoptotic Activities of ING1 Tumor Suppressor. J Mol Biol. 2008; 380: 303-312. doi: 10.1016/j.jmb.2008.04.061 PMID: 18533182
63. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, et al. A high-resolution map of active promoters in the human genome. Nature. 2005; 436: 876-880. doi: 10.1038/nature03877 PMID: 15988478
64. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Research. 2007. pp. 691-707. doi: 10.1101/gr.5704207 PMID: 17567990
65. Tae HK, Barrera LO, Qu C, Van Calcar S, Trinklein ND, Cooper SJ, et al. Direct isolation and identification of promoters in the human genome. Genome Res. 2005; 15: 830-839. doi: 10.1101/gr.3430605 PMID: 15899964
66. Clouaire T, Webb S, Skene P, Illingworth R, Kerr A, Andrews R, et al. Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev. 2012; 26: 1714-1728. doi: 10.1101/gad.194209.112 PMID: 22855832
67. Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. The EMBO Journal. 2011. pp. 4198-4210. doi: 10.1038/emboj.2011.295 PMID: 21847099
68. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007; 448: 553-560. doi: 10.1038/nature06008 PMID: 17603471
69. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458: 223-227. doi: 10. 1038/nature07672 PMID: 19182780
70. Connor C, Cheung I, Simon A, Jakovcevski M, Weng Z, Akbarian S. A simple method for improving the specificity of anti-methyl histone antibodies. Epigenetics. 2010; 5: 392-395. doi: 10.4161/epi.5.5.11874 PMID: 20458167
71. Heidari N, Phanstiel DH, He C, Grubert F, Jahanbanian F, Kasowski M, et al. Genome-wide map of regulatory interactions in the human genome. Genome Res. 2014; gr.176586.114-. doi: 10.1101/gr. 176586.114
72. Bharadwaj R, Jiang Y, Mao W, Jakovcevski M, Dincer A, Krueger W, et al. Conserved Chromosome 2q31 Conformations Are Associated with Transcriptional Regulation of {GAD1} {GABA} Synthesis Enzyme and Altered in Prefrontal Cortex of Subjects with Schizophrenia. J Neurosci. 2013; 33: 11839-11851. doi: 10.1523/JNEUROSCI.1252-13.2013 PMID: 23864674
73. Bharadwaj R, Peter CJ, Jiang Y, Roussos P, Vogel-Ciernia A, Shen EY, et al. Conserved higher-order chromatin regulates NMDA receptor gene expression and cognition. Neuron. 2014; 84: 997-1008. doi: 10.1016/j.neuron.2014.10.032 PMID: 25467983
74. Unland R, Kerl K, Schlosser S, Farwick N, Plagemann T, Lechtape B, et al. Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system. J Neurooncol. 2014; 116: 237-249. doi: 10.1007/s11060-013-1313-1 PMID: 24264533
75. Shulha HP, Cheung I, Whittle C, Wang J, Virgil D, Lin CL, et al. Epigenetic Signatures of Autism: Trimethylated H3K4 Landscapes in Prefrontal Neurons. Archives of General Psychiatry. 2012. pp. 314- 324. doi: 10.1001/archgenpsychiatry.2011.151 PMID: 22065254
76. Langmead B. Aligning short sequencing reads with Bowtie. Curr Protoc Bioinforma. 2010; doi: 10.1002/0471250953.bi1107s32
77. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9: R137. doi: 10.1186/gb-2008-9-9-r137 PMID: 18798982
78. Li C, Wong W, Hung Wong W. Model-based analysis of oligonucleotide arrays: Model validation, design issues and standard error application. Genome Biol. 2001; 2: RESEARCH0032. Available: Http://www.biomedcentral.com/content/pdf/gb-2001-2-8-research0032.pdf PMID: 11532216
79. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15: 550. doi: 10.1186/s13059-014-0550-8 PMID: 25516281
80. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: The reference human genome annotation for the ENCODE project. Genome Res. 2012; 22: 1760-1774. doi: 10.1101/gr.135350.111 PMID: 22955987
81. Quinlan AR, Hall IM. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics. 2010; 26: 841-842. doi: 10.1093/bioinformatics/btq033 PMID: 20110278
82. Young MD, Wakefield MJ, Smyth GK, Oshlack A. Gene ontology analysis for RNA-seq: Accounting for selection bias. Genome Biol. 2010; 11: R14. doi: 10.1186/gb-2010-11-2-r14 PMID: 20132535
83. Supek F, Bosnjak M, Škunca N, Šmuc T. Revigo summarizes and visualizes long lists of gene ontology terms. PLoS One. 2011; 6. doi: 10.1371/journal.pone.0021800
84. Zhang JD, Wiemann S. KEGGgraph: A graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics. 2009; 25: 1470-1471. doi: 10.1093/bioinformatics/btp167 PMID: 19307239
85. James Kent W, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002; 12: 996-1006. doi: 10.1101/gr.229102 Article published online before print in May 2002 PMID: 12045153
86. Wang J, Zhuang J, Iyer S, Lin X, Whitfield TW, Greven MC, et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. Cold Spring Harbor Lab; 2012; 22: 1798-1812. doi: 10.1101/gr.139105.112 PMID: 22955990
87. Wang J, Zhuang J, Iyer S, Lin X-Y, Greven MC, Kim B-H, et al. Factorbook. org: A Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic Acids Res. Oxford Univ Press; 2012;
88. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013; 153: 307-319. doi: 10. 1016/j.cell.2013.03.035 PMID: 23582322